Katonah, NY, United States of America

Meghan Drummond Samuelson

This inventor holds 8 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Regeneron Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meghan Drummond Samuelson. Retrieved from https://idiyas.com/inventor/meghan-drummond-samuelson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.5

ph-index = 1


Location History:

  • Tarrytown, NY (US) (2023)
  • Katonah, NY (US) (2022 - 2024)

Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Meghan Drummond Samuelson

Introduction

Meghan Drummond Samuelson is a prominent inventor based in Katonah, NY (US). She has made significant contributions to the field of auditory health, particularly in the treatment of hearing loss. With a total of 8 patents, her work focuses on innovative therapies that address complex auditory conditions.

Latest Patents

One of her latest patents is titled "Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems." This patent features compositions and methods aimed at treating sensorineural hearing loss and auditory neuropathy, especially those associated with mutations in the otoferlin (OTOF) gene. The disclosure includes a variety of compositions that utilize a first nucleic acid vector encoding an N-terminal portion of an OTOF protein and a second nucleic acid vector encoding a C-terminal portion of the same protein. These vectors are designed to enhance the expression of OTOF in individuals suffering from sensorineural hearing loss.

Another significant patent is "Kelch domain containing 7B (KLHDC7B) variants and uses thereof." This patent provides methods for treating individuals with hearing loss, identifying those at increased risk of developing hearing loss, and detecting KLHDC7B variant nucleic acid molecules and polypeptides.

Career Highlights

Throughout her career, Meghan has worked with notable companies such as Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc. Her innovative approaches have positioned her as a key figure in the development of therapies for hearing loss.

Collaborations

Meghan has collaborated with esteemed colleagues, including Brian Zambrowicz and Andrew J Murphy. These partnerships have furthered her research and contributed to her success in the field.

Conclusion

Meghan Drummond Samuelson's contributions to auditory health through her innovative patents and collaborations highlight her as a leading inventor in the field. Her work continues to pave the way for advancements in the treatment of hearing loss.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…